Skip to main content

Advertisement

Table 1 IDH1 mutation and MGMT promoter methylation status of GBM cell lines and primary cells

From: Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Cells IDH1 MGMT promoter
U251-MG Wild-type Methylated
U373-MG Wild-type Methylated
U87-MG Wild-type Methylated
Primary culture Wild-type Methylated